Navigation Links
Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
Date:9/28/2010

CHADDS FORD, Pa., Sept. 28 /PRNewswire-FirstCall/ --

  • Diversifies Revenue Streams and Boosts Scale in Existing Generics Business, and Strengthens Core Pain Franchise
  • Transaction Expected to be Immediately Accretive to Adjusted Diluted Earnings per Share by $0.40 in First Full Year After Close
  • Company Reiterates Full-Year 2010 Financial Guidance

  • Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately-held generics company in the U.S., for approximately $1.2 billion in cash. The combined company will deliver more comprehensive healthcare solutions across its diversified businesses in Branded Pharmaceuticals, Generics, Devices & Services in key therapeutic areas including pain and urology.  

    Qualitest, the sixth largest U.S. generics company as measured by prescriptions filled, is focused on cost competitive, high quality manufactured products with high barriers to entry. Qualitest has cGMP facilities in the U.S. including the ability to manufacture controlled substances, which make up approximately 40 percent of its product portfolio, and liquids, which are roughly 17 percent of its portfolio. The company brings a broad range of generics to Endo encompassing 175 product families. Thirty-two of Qualitest's products are listed among the top 250 generics by total prescription (TRx) volume. In addition, the combined company will have an extensive pipeline of abbreviated new drug applications (ANDAs) with 46 ANDAs under active FDA review in multiple therapeutic areas, including pain, urology, CNS, as well as oncology and hypertension and an additional 24 ANDAs under development in multiple therapeutic areas.

    Endo believes Qualitest brings critical mass to Endo's current generics business, further diversifies
    '/>"/>

    SOURCE Endo Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Ohio , Jan. 15, 2014  A novel wearable injector ... easy and painless for patients to self-inject prescription drugs in ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to grow to $220B by 2018, according to analysts.   Many ...
    (Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ...
    (Date:1/14/2014)... Inc. , a privately held company pioneering the development ... related neurodegenerative disorders, announced today the relocation of its ... as of January 15, 2014 and expanded lease agreement ... Oligomerix, which is focused on the development ...
    Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
    ... Corporation announced today that it has received U.S. ... the HypothermX™ HX100 device.  The HypothermX™ HX100 device ... designed to warm intravenous fluids, blood or blood ... treat trauma, environmental, procedure related, or induced hypothermia. ...
    ... Fla., May 26, 2011 Hope Paige Designs, a company ... medical ID jewelry , will now be available in an ... total amount of pharmacies that carries its products to more ... to traditional medical alert jewelry and accessories, offering stylish key ...
    Cached Medicine Technology:EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer. 2
    (Date:4/18/2014)... to enter the battle against infectious disease. This ... remote areas, thanks in part to knowledge gained ... Space Station on the behavior of liquids. The ... to diagnose infectious diseases such as HIV/AIDS and ... Northwestern University in Evanston, Ill., had been working ...
    (Date:4/18/2014)... worst memories? How did it make you feel? According ... personal experience, such as how sad you were or ... especially when you can,t stop thinking about it. ... the context of the memories, rather than how you ... alleviate the negative effects of these memories, a new ...
    (Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
    (Date:4/17/2014)... variant specifically associated with the risk of a ... cent of all breast cancer cases. , The ... called invasive lobular carcinoma, gives researchers important clues ... of breast cancer, which can be missed through ... the journal PloS Genetics , was co-led ...
    (Date:4/17/2014)... In the April issue of Experimental Biology ... by Drs. Rex Gaskins and Paul Kenis in ... campus of the University of Illinois Urbana-Champaign describe ... reduction-oxidation reactions underlie a variety of cell functions ... to these crucial roles in regulating normal cellular ...
    Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2
    ... brought relief from chronic pain, study found , , FRIDAY, ... heated swimming pool can benefit people with the common, ... Symptoms of fibromyalgia include chronic and severe pain and ... pain; sleep problems; anxiety and depression. Women account for ...
    ... buster works longer than thought, lowering blood pressure limits ... 8 hours , , FRIDAY, Feb. 22 (HealthDay News) -- ... ways to treat different types of stroke. , The ... American Stroke Association,s International Stroke Conference in New Orleans. ...
    ... Lead,Poisoning Prevention Project of Saginaw, the Detroit Department ... Healthy Homes Coalition of West,Michigan have been awarded ... Environmental Protection Agency Region 5,s grant,program is part ... poisoning as,a major public health concern by 2010., ...
    ... The University of Illinois,School of Public Health and ... American Pediatrics Association and the Chicago,Department of Public ... lead,poisoning prevention projects. U.S. Environmental Protection Agency Region,5,s ... to eliminate childhood lead,poisoning as a major public ...
    ... GAITHERSBURG, Md., Feb. 22 Professional Products, Inc.,(PPI) ... Hospital located,in Baltimore, Maryland with a Clinical Skills ... center is on the eighth floor of the,outpatient ... their teaching,capabilities. This center allows future doctors the ...
    ... Perot Systems Implementing NextGen(R) Suite of Integrated Electronic ... Medical Records and Practice Management Applications, ... (NYSE: PER ) and Oakwood Healthcare announced ... medical,records program are delivering significant, positive results. After ...
    Cached Medicine News:Health News:Aquatic Exercises May Ease Fibromyalgia 2Health News:New Stroke Therapies Show Promise 2Health News:New Stroke Therapies Show Promise 3Health News:EPA Funds Grants for Four Lead Poisoning Prevention Projects in Michigan Communities 2Health News:EPA Funds Two Grants for Lead Poisoning Prevention Projects in Chicago Communities 2Health News:Professional Products, Inc. Integrates Clinical Skills and Simulation Center at the Johns Hopkins Hospital 2Health News:Perot Systems and Oakwood Healthcare Deliver Advanced Technology & Revenue Cycle Solutions to Physicians 2Health News:Perot Systems and Oakwood Healthcare Deliver Advanced Technology & Revenue Cycle Solutions to Physicians 3
    Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
    Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
    Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
    Used for the introduction of catheters, balloons and other vascular devices....
    Medicine Products: